DTCAX
Price
$19.29
Change
-$0.00 (-0.00%)
Updated
Nov 4 closing price
FXAIX
Price
$198.55
Change
-$0.00 (-0.00%)
Updated
Nov 4 closing price
Ad is loading...

DTCAX vs FXAIX

Header iconDTCAX vs FXAIX Comparison
Open Charts DTCAX vs FXAIXBanner chart's image
BNY Mellon Sust US Equity A
Price$19.29
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Fidelity 500 Index
Price$198.55
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
DTCAX vs FXAIX Comparison Chart
Loading...
VS
DTCAX vs. FXAIX commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTCAX is a StrongBuy and FXAIX is a Buy.

FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 593B vs. DTCAX (482M). FXAIX pays higher dividends than DTCAX: FXAIX (1.31) vs DTCAX (0.47). DTCAX was incepted earlier than FXAIX: DTCAX (25 years) vs FXAIX (14 years). DTCAX is a more actively managed with annual turnover of: 21.98 vs. FXAIX (3.00). FXAIX has a lower initial minimum investment than DTCAX: FXAIX (0) vs DTCAX (1000). FXAIX (32.96) and DTCAX (31.58) have marching annual gain over last year. FXAIX return over 5 years is better than : 99.78 vs. DTCAX (52.10).
DTCAXFXAIXDTCAX / FXAIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years14 years-
Gain YTD22.94521.131109%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets482M593B0%
Annual Yield % from dividends0.471.3136%
Returns for 1 year31.5832.9696%
Returns for 3 years-2.8227.36-10%
Returns for 5 years52.1099.7852%
Returns for 10 years27.64205.4213%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FIZZ47.701.93
+4.22%
National Beverage Corp
PRAX69.991.66
+2.43%
Praxis Precision Medicines
CSGP73.831.33
+1.83%
CoStar Group
SGC15.140.12
+0.80%
Superior Group of Companies
AEON0.88N/A
-0.10%
AEON Biopharma